Highlights
NASDAQ: ATOS       Atossa Genetics Inc
Last Price Today's Change   Day's Range   Trading Volume
2.31   +0.04 (1.76%)  2.18 - 2.55  297,320

Overview

 
Avg Volume (4 weeks):909,784
4 Weeks Range:1.45 - 2.68
4 Weeks Price Volatility (%):
69.92%
52 Weeks Range:0.75 - 3.25
52 Weeks Price Volatility (%):
62.40%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Atossa Genetics Inc is a clinical-stage pharmaceutical company operating in the US. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The clinical-Stage Programs of the company includes delivery of therapeutics through microcatheters which delivers a number of therapeutics to the ducts in the breast, the site of the majority of early breast cancers and fulvestrant Delivered through microcatheters which delivers fulvestrant as a potential treatment of ductal carcinoma in-situ (DCIS) and breast cancer. In addition, the company involves in the process of evaluating additional potential indications of endoxifen and other therapeutic candidates to treat breast conditions, including breast cancer.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2027  3695  322  2908 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 JCP 0.1820.00 
 ADAP 11.635+6.775 
 GE 6.50-0.28 
 AVP 5.60-0.05 
 PRTY 1.31+0.29 
 PHIO 3.64+1.40 
 NERV 3.302-10.168 
 F 5.66-0.19 
 AABA 19.630.00 
 SQQQ 9.80-0.03 
Partners & Brokers